Identification of new target proteins for pancreatic carcinoma Early stages of pancreatic tumors often cause no symptoms, while later-stage symptoms are often nonspecific. Pancreatic cancer is therefo

ERA-Net Eurotransbio: Models for Alzheimer's and similar diseases, drug development based on the mitochondrial cascade hypothesis Mitochondria are the powerhouses of cells. Recent investigations sugge

Identifizierung von Biomarkern zur Vorhersage des Ansprechens und der Resistenz gegenüber VEGFR/mTOR-Inhibitoren beim Nierenkarzinom

Agents are tested using neurons derived from induced pluripotent stem cells in comparison to animal models. Neurons derived from induced pluripotent stem cells (iPSCs) can be used as a relevant, near-

In a new approach, genetic tools are used to introduce additional mitochondrial dysfunction into transgenic mice with pathogenic Alzheimer's disease proteins to model age-related metabolic deficits. I

Traumatic experiences and stress are major contributors to anxiety disorders. In this context, a specific brain region, the amygdala, plays an important role by modulating other brain regions, such as

Psychoses describe an extremely heterogeneous group of diseases. As a result, diagnoses, prognoses and treatment decisions for individual patients are challenging. Within the project, biomarker signat

High-throughput sequencing of all mRNA molecules from patient tissues is used for personalized, predictive diagnostics as well as drug testing in vitro. Since the brain is not readily accessible for t

For 26 years, Prof. Hansjürgen Volkmer shaped the NMI with his work. He has contributed his knowledge and commitment to the NMI since 1998. Today, Hansjürgen Volkmer retired with a colloquium. For 26

A delegation from the NMI is at the annual conference of the German Society for Biomaterials. They will be presenting two projects and providing initial insights into the new VDI guideline on 3D biopr